WuXi Biologics Secures South Korea GMP Certification for Key Manufacturing Facilities
The South Korea GMP Certification from the Ministry of Food and Drug Safety strengthens WuXi Biologics’ end-to-end capabilities for commercial production of complex biologics, including cancer therapies.
Contract Manufacturing | 23/04/2026 | By News Bureau
Great Point Partners Announces Acquisition of Lyocontract
Great Point Partners (GPP) has acquired Lyocontract GmbH (Lyocontract), a premium independent drug product contract development and manufacturing organization (CDMO) based in Ilsenburg, Germany.
Contract Manufacturing | 15/06/2024 | By Aishwarya | 493
SCHOTT Pharma Launches State-of-the-Art Production Facility in Hungary
SCHOTT Pharma has inaugurated its new production facility for high-quality prefillable glass syringes in Hungary.
Contract Manufacturing | 12/06/2024 | By Aishwarya | 550
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy